Dopaminergic and cholinergic influences on the growth hormone response to growth hormone-releasing hormone in man.
It is well established that compounds that modify dopaminergic and cholinergic activity in man may induce changes in circulating growth hormone (GH). We have, therefore, investigated the effect of a dopamine agonist, bromocriptine, and a dopamine antagonist, domperidone, as well as a muscarinic chol...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1987
|